Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spero Therapeutics Inc.

2.50
-0.0600-2.34%
Post-market: 2.520.0200+0.80%19:48 EDT
Volume:2.55M
Turnover:6.55M
Market Cap:139.78M
PE:-1.95
High:2.74
Open:2.54
Low:2.45
Close:2.56
Loading ...

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

Zacks
·
29 May

Top Midday Gainers

MT Newswires Live
·
29 May

Crude Oil Gains 2%; Macy's Lowers Earnings Forecast

Benzinga
·
29 May

Spero Therapeutics' Shares More Than Triple to $2.11 After Co to Stop Urinary Tract Infection Drug Trial Due to Early Success

THOMSON REUTERS
·
28 May

Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data

TIPRANKS
·
28 May

GSK reports PIVOT-PO study for tebipenem HBr stopped early for efficacy

TIPRANKS
·
28 May

Spero Therapeutics' Shares Nearly Triple to $2 Premarket After Co to Stop Urinary Tract Infection Drug Trial Due to Early Success

THOMSON REUTERS
·
28 May

Spero Therapeutics Announces Early Success in Phase 3 Trial of Tebipenem HBr for Complicated UTIs, Plans FDA Filing in 2025

Reuters
·
28 May

GSK, Spero to stop urinary tract infection drug trial due to early success

Reuters
·
28 May

TD Cowen Reaffirms Their Hold Rating on Spero Therapeutics (SPRO)

TIPRANKS
·
19 May

Spero Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Spero Therapeutics Q1 EPS USD -0.25

Reuters
·
14 May

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

THOMSON REUTERS
·
14 May

Spero Therapeutics Q1 EPS USD -0.25

THOMSON REUTERS
·
14 May

Spero Therapeutics Inc - Expects Cash, Earned Milestones to Cover Expenses Into Q2 2026

THOMSON REUTERS
·
14 May

Spero Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview

Reuters
·
10 May

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

THOMSON REUTERS
·
05 May

BRIEF-Spero Therapeutics Appoints Esther Rajavelu As President And Chief Executive Officer

Reuters
·
29 Apr

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

THOMSON REUTERS
·
29 Apr

Press Release: Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

Dow Jones
·
29 Apr